Literature DB >> 9695692

Prostate-specific antigen testing for prostate cancer: the case for informed consent.

M McCredie, B Cox.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9695692     DOI： 10.5694/j.1326-5377.1998.tb141467.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  2 in total

1.  A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer.

Authors:  Robert U Newton; Dennis R Taaffe; Nigel Spry; Robert A Gardiner; Gregory Levin; Bradley Wall; David Joseph; Suzanne K Chambers; Daniel A Galvão
Journal:  BMC Cancer       Date:  2009-06-29       Impact factor: 4.430

2.  Can exercise ameliorate treatment toxicity during the initial phase of testosterone deprivation in prostate cancer patients? Is this more effective than delayed rehabilitation?

Authors:  Robert U Newton; Dennis R Taaffe; Nigel Spry; Prue Cormie; Suzanne K Chambers; Robert A Gardiner; David Hk Shum; David Joseph; Daniel A Galvão
Journal:  BMC Cancer       Date:  2012-09-26       Impact factor: 4.430
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.